About Predictmedix
Predictmedix is a Life Sciences technology company developing AI-powered products to improve workplace health and safety, enhance protection in public environments, and provide tools for medical professionals to better care for patients.
Our Team
Dr. Rahul Kushwah
COO, Director
PhD, Banting Fellow. Developed world’s first genetic test for cannabis pharmacogenetics. Previously on the National Research Council for the Government of Canada in Human Health Therapeutics. Expertise in human diseases, genetics, immunology and regenerative/personalized
Recent Press
Predictmedix AI Announces Non-Brokered Private Placement
Toronto, Ontario–(Newsfile Corp. – October 20, 2025) – Predictmedix AI Inc. (CSE: PMED) (OTC Pink: PMEDF) (FSE: 3QP0) (“Predictmedix” or the “Company”), an emerging leader in AI-powered health and safety technology, announces a proposed non brokered private placement. The Company intends to issue (the “Offering”) of up to 18,000,000 units (each, a “Unit”) at a […]
Predictmedix AI to Present at the 25th MK Investment Conference in Munich, Germany
TORONTO–Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP0) (“Predictmedix” or the “Company”), an emerging leader in AI-powered health and safety technology, is pleased to announce that its Chief Operating Officer and Co-founder, Dr. Rahul Kushwah, will be presenting at the prestigious 25th MK Investment Conference in Munich, Germany, on October 1, 2025. The MK […]
Predictmedix AI Announces Multi-Vertical Growth Strategy to Become an AI Health-Technology Leader
Clinically validated SmartHealth AI Stations anchor expansion into Clinical-Trial Optimization and Consumer Digital Health, creating multiple recurring-revenue opportunities TORONTO-Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP0) (“Predictmedix” or the “Company”), an emerging leader in AI-powered health and safety technology, today outlined a strategic plan to evolve from a single-product health-screening company into a diversified, […]